Multiple Stress Signals Activate Mutant p53 In Vivo
- 29 November 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (23), 7168-7175
- https://doi.org/10.1158/0008-5472.can-11-0459
Abstract
P53 levels are tightly regulated in normal cells, and thus, the wild-type p53 protein is nearly undetectable until stimulated through a variety of stresses. In response to stress, p53 is released from its negative regulators, mainly murine double minute 2 (Mdm2), allowing p53 to be stabilized to activate cell-cycle arrest, senescence, and apoptosis programs. Many of the upstream signals that regulate wild-type p53 are known; however, limited information for the regulation of mutant p53 exists. Previously, we showed that wild-type and mutant p53R172H are regulated in a similar manner in the absence of Mdm2 or p16. In addition, this stabilization of mutant p53 is responsible for the gain-of-function metastatic phenotype observed in the mouse. In this report, we examined the role of oncogenes, DNA damage, and reactive oxygen species, signals that stabilize wild-type p53, on the stabilization of mutant p53 in vivo and the consequences of this expression on tumor formation and survival. These factors stabilized mutant p53 protein which oftentimes contributed to exacerbated tumor phenotypes. These findings, coupled with the fact that patients carry p53 mutations without stabilization of p53, suggest that personalized therapeutic schemes may be needed for individual patients depending on their p53 status. Cancer Res; 71(23); 7168–75. ©2011 AACR.Keywords
This publication has 41 references indexed in Scilit:
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor DevelopmentCancer Cell, 2010
- p53-dependent senescence delays Eμ-myc-induced B-cell lymphomagenesisOncogene, 2009
- Trim24 targets endogenous p53 for degradationProceedings of the National Academy of Sciences, 2009
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a lossGenes & Development, 2008
- Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53Free Radical Biology & Medicine, 2007
- p53 mutation heterogeneity in cancerBiochemical and Biophysical Research Communications, 2005
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985